Bone marrow-derived mesenchymal stem cells in the treatment of myocardial infarction / 中国医学科学院学报
Zhongguo yi xue ke xue yuan xue bao
; Zhongguo yi xue ke xue yuan xue bao;(6): 108-112, 2015.
Article
en En
| WPRIM
| ID: wpr-257673
Biblioteca responsable:
WPRO
ABSTRACT
Bone marrow-derived mesenchymal stem cells (BMSCs) have the ability to regenerate myocadial tissue. BMSCs transplantation can produce cardiac-like cells,promote angiogenesis, and secrete a variety of growth factors and cytokines. This article summarizes the molecular mechanisms of myocardial repair, explores the potential regenerative capacity of cardiac muscles after myocardial infarction,and reviews the previous studies on BMSC transplantation for treatment of cardiac muscle after myocardial infarction, with an attempt to provide new insights in clinical decision-making.
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Cicatrización de Heridas
/
Médula Ósea
/
Citocinas
/
Células Madre Mesenquimatosas
/
Corazón
/
Infarto del Miocardio
/
Miocardio
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Zhongguo yi xue ke xue yuan xue bao
Año:
2015
Tipo del documento:
Article